| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 8.8% stake in Affimed N.V. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 8.8% stake in Affimed N.V. |
| 02/14/2023 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 7.6% stake in Bicycle Therapeutics plc |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Cogent Biosciences Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 6.5% stake in Affimed N.V. |
| 04/14/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Verastem, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 2.5% stake in Sutro Biopharma, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 2.3% stake in Myomo, Inc. |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 4.5% stake in F-star Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 4.2% stake in 4D Molecular Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/23/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 5.4% stake in 4D Molecular Therapeutics, Inc. |
| 08/24/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 5.3% stake in Sutro Biopharma, Inc. |
| 07/16/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/13/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 6.3% stake in Bicycle Therapeutics plc |
| 03/06/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/24/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 6.3% stake in Myomo, Inc. |
| 02/14/2020 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Karyopharm Therapeutics Inc. |
| 01/21/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 12.6% stake in Verastem, Inc. |
| 01/06/2020 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 6.9% stake in Spring Bank Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 6.5% stake in Karyopharm Therapeutics Inc. |
| 03/15/2018 |
SC 13G
| Ridgeback Capital Investments L.P. reports a 5.2% stake in Corium International, Inc. |
| 02/14/2018 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in Verastem, Inc. |
| 01/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/20/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/30/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|